The efficacy of oral deferiprone in acute iron poisoning

American Journal of Emergency Medicine

Volumn 18, Issue 1, 2000, Pages 36-40

  Berkovitch, Matitiahu ^a,d   Livne, Amir ^a   Lushkov, Gili ^a   Segal, Michael ^a   Talmor, Clara ^a   Bentur, Yedidia ^b   Klein, Julia ^c   Koren, Gideon ^c  

^a TEL AVIV UNIVERSITY   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d ASSAF HAROFEH MEDICAL CENTER   (Israel)

Author keywords

Acute iron intoxication; Deferiprone; Rats

Indexed keywords

DEFERIPRONE; IRON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; HISTOLOGY; IRON OVERLOAD; MALE; MORBIDITY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE SPECIFICITY;

EID: 0033969435     PISSN: 07356757     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-6757(00)90045-7     Document Type: Article

References (14)

1. Berkovitch M, Matsui D, Lamm SH, et al: Recent increases in numbers and risk of fatalities in young children ingesting iron preparations. Vet Hum Toxicol 1994;36:53-55
2. Litovitz TL, Holm KC, Clancy C, et al: 1992 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 1993;11:494-555
3. Proudfoot AT, Simpson D, Dyson EH: Management of acute iron poisoning. Med Toxicol 1986;1:83-100
4. Cohen AR: Management of iron overload in the pediatric patient. Hematol Oncol Clin North Am 1987;1:521-544
5. Dart RC, Stark Y, Fulton B, et al: Insufficient stocking of poisoning antidotes in hospital pharmacies. JAMA 1996;276:1508-1510
6. Olivieri NF, Brittenham GM, Matsui D, et al: Iron chelation therapy with oral deferiprone in patients with thalassemia major. N Engl J Med 1995;332:918-922
7. 1 (1,2-dimethyl-3-hydroxypyrid-4-one) for oral iron chelation in patients with beta-thalassasemia major. Br J Haematol 1990;76:550-553
8. Fassos FF, Berkovitch M, Daneman N, et al: Efficavy of deferiprone in the treatment of acute iron intoxication in rats. Clinical Toxicology 1996;34:279-287
9. Berkovitch M, Livne A, Lushkov G, et al: Acute iron intoxication: Significant differences between sexes. Vet Hum Toxicol 1997;39:265-267
10. Klein J, Damani LA, Chung D, et al: A high performance liquid chromatographic method for the measurement of the iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one in human plasma. Ther Drug Monit 1991;13:51-54
11. Kontoghiorghes GJ, Hoffbrand AV: Orally active alpha-ketohydroxy pyridine iron chelators intended for clinical use: In vivo studies in rabbits. Br J Haematol 1986;62:607-613
12. Tenenbein M, Kowalski S, Sienko A, et al: Pulmonary toxic effects of continuous desferrioxamine administration in acute iron poisoning. Lancet 1992;339:699-701
13. 1) in thalassemia major. Blood 1992;80:593-599
14. Brittenham GM: Development of iron - chelating agents for clinical use. Blood 80:569-574, 1992